Viewing Study NCT02518295


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2026-02-27 @ 8:48 AM
Study NCT ID: NCT02518295
Status: COMPLETED
Last Update Posted: 2016-11-30
First Post: 2015-07-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion
Sponsor: Société des Produits Nestlé (SPN)
Organization:

Study Overview

Official Title: β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion: Probiotic and Lactose Intolerance
Status: COMPLETED
Status Verified Date: 2016-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess that two β-galactosidase Producing Probiotic Strains help improve lactose digestion in subjects with lactose maldigestion.
Detailed Description: The trial will be cross over, randomized in incomplete blocks, controlled, double-blind:

each subject will be administered 3 products out of 4 (positive control, probiotic Streptococcus (S.) thermophilus, probiotic Bifidobacterium (B.) longum, negative control) in a random order on 3 different days separated by a washout period of at least one week, and maximum 2 weeks between each challenge.

The total sample size is 42 enrolled subjects/37 completed Patients will be males and females aged between 20 and 65 years with positive hydrogen breath test.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: